These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
461 related articles for article (PubMed ID: 27350898)
1. Integrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasis. Ab Mutalib NS; Othman SN; Mohamad Yusof A; Abdullah Suhaimi SN; Muhammad R; Jamal R PeerJ; 2016; 4():e2119. PubMed ID: 27350898 [TBL] [Abstract][Full Text] [Related]
2. Integrated Characterization of MicroRNA and mRNA Transcriptome in Papillary Thyroid Carcinoma. Mohamad Yusof A; Jamal R; Muhammad R; Abdullah Suhaimi SN; Mohamed Rose I; Saidin S; Ab Mutalib NS Front Endocrinol (Lausanne); 2018; 9():158. PubMed ID: 29713312 [TBL] [Abstract][Full Text] [Related]
3. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer. Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287 [TBL] [Abstract][Full Text] [Related]
4. hsa-miR-206b Involves in the Development of Papillary Thyroid Carcinoma via Targeting LMX1B. Lu H; Zhu C; Ruan Y; Fan L; Ruan Z; Chen Q; Yuan J; Xu Y; Wang H; Wei Q Biomed Res Int; 2022; 2022():7488708. PubMed ID: 35342753 [TBL] [Abstract][Full Text] [Related]
5. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis. Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894 [TBL] [Abstract][Full Text] [Related]
6. Plasma Exosomal miR-146b-5p and miR-222-3p are Potential Biomarkers for Lymph Node Metastasis in Papillary Thyroid Carcinomas. Jiang K; Li G; Chen W; Song L; Wei T; Li Z; Gong R; Lei J; Shi H; Zhu J Onco Targets Ther; 2020; 13():1311-1319. PubMed ID: 32103998 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM. Elango R; Alsaleh KA; Vishnubalaji R; Manikandan M; Ali AM; Abd El-Aziz N; Altheyab A; Al-Rikabi A; Alfayez M; Aldahmash A; Alajez NM Front Oncol; 2020; 10():756. PubMed ID: 32509578 [TBL] [Abstract][Full Text] [Related]
8. Identification of key miRNAs in papillary thyroid carcinoma based on data mining and bioinformatics methods. Wang J; Wu L; Jin Y; Li S; Liu X Biomed Rep; 2020 Jan; 12(1):11-16. PubMed ID: 31839944 [TBL] [Abstract][Full Text] [Related]
9. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis. Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912 [TBL] [Abstract][Full Text] [Related]
10. Expression profiling and bioinformatics analysis of serum exosomal circular RNAs in lymph node metastasis of papillary thyroid carcinoma. Peng H; Zhu Z; Xing J; Xu Q; Man C; Wang S; Liu Y; Zhang Z J Biomed Res; 2024 May; ():1-15. PubMed ID: 38812291 [TBL] [Abstract][Full Text] [Related]
11. Identification of Potential lncRNAs and miRNAs as Diagnostic Biomarkers for Papillary Thyroid Carcinoma Based on Machine Learning. Yang F; Zhang J; Li B; Zhao Z; Liu Y; Zhao Z; Jing S; Wang G Int J Endocrinol; 2021; 2021():3984463. PubMed ID: 34335744 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of miR-2861 and miR-451 expression in papillary thyroid carcinoma with lymph node metastasis. Wang Z; Zhang H; Zhang P; Li J; Shan Z; Teng W Med Oncol; 2013; 30(2):577. PubMed ID: 23609190 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of plasma exosomal miRNAs as potential diagnostic biomarkers of lymph node metastasis in papillary thyroid carcinoma. Chen W; Li G; Li Z; Zhu J; Wei T; Lei J Endocrine; 2022 Mar; 75(3):846-855. PubMed ID: 34854020 [TBL] [Abstract][Full Text] [Related]
14. Exosomal hsa-miR-129-2 and hsa-miR-889 from a 6-microRNA Signature Might be a Potential Biomarker for Predicting the Prognosis of Papillary Thyroid Carcinoma. Xin Y; Meng K; Guo H; Chen B; Zheng C; Shou X; Yu K Comb Chem High Throughput Screen; 2022; 25(5):819-830. PubMed ID: 33550967 [TBL] [Abstract][Full Text] [Related]
15. Identification of differentially expressed miRNAs in early-stage cervical cancer with lymph node metastasis across The Cancer Genome Atlas datasets. Chen Q; Zeng X; Huang D; Qiu X Cancer Manag Res; 2018; 10():6489-6504. PubMed ID: 30568508 [TBL] [Abstract][Full Text] [Related]
16. Dysregulation of microRNAs as the risk factor of lymph node metastasis in papillary thyroid carcinoma: systematic review. Laukiene R; Jakubkevicius V; Ambrozaityte L; Cimbalistiene L; Utkus A Endokrynol Pol; 2021; 72(2):145-152. PubMed ID: 33970479 [TBL] [Abstract][Full Text] [Related]
17. MiR-324-5p assists ultrasonography in predicting lymph node metastasis of unifocal papillary thyroid microcarcinoma without extracapsular spread. Yang Y; Xia S; Ni X; Ni Z; Zhang L; Wang W; Kong Y; Wang Y; Ye L; Zhan W Oncotarget; 2017 Oct; 8(48):83802-83816. PubMed ID: 29137384 [TBL] [Abstract][Full Text] [Related]
18. Potential diagnostic of lymph node metastasis and prognostic values of TM4SFs in papillary thyroid carcinoma patients. Wang K; Li H; Zhao J; Yao J; Lu Y; Dong J; Bai J; Liao L Front Cell Dev Biol; 2022; 10():1001954. PubMed ID: 36568979 [No Abstract] [Full Text] [Related]
19. miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma. Minna E; Romeo P; Dugo M; De Cecco L; Todoerti K; Pilotti S; Perrone F; Seregni E; Agnelli L; Neri A; Greco A; Borrello MG Oncotarget; 2016 Mar; 7(11):12731-47. PubMed ID: 26871295 [TBL] [Abstract][Full Text] [Related]